PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 4 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $3,242,000 | +1066.2% | 853,416 | +1458.2% | 0.05% | +1466.7% |
Q4 2019 | $278,000 | +28.1% | 54,769 | +43.7% | 0.00% | -40.0% |
Q3 2015 | $217,000 | -78.1% | 38,108 | -71.1% | 0.01% | -77.3% |
Q2 2015 | $991,000 | -0.4% | 131,644 | -14.1% | 0.02% | +10.0% |
Q1 2015 | $995,000 | +107.3% | 153,238 | +145.1% | 0.02% | +122.2% |
Q4 2014 | $480,000 | -46.1% | 62,530 | -61.9% | 0.01% | -52.6% |
Q3 2014 | $891,000 | -13.4% | 164,066 | -31.2% | 0.02% | -13.6% |
Q2 2014 | $1,029,000 | +32.9% | 238,437 | +26.8% | 0.02% | +37.5% |
Q1 2014 | $774,000 | +5853.8% | 188,064 | +95364.0% | 0.02% | – |
Q4 2013 | $13,000 | +550.0% | 197 | +535.5% | 0.00% | – |
Q3 2013 | $2,000 | – | 31 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|